Cargando…
MicroRNAs as biomarkers of diabetic retinopathy and disease progression
Diabetes mellitus, together with its complications, has been increasing in prevalence worldwide. Its complications include cardiovascular disease (e.g., myocardial infarction, stroke), neuropathy, nephropathy, and eye complications (e.g., glaucoma, cataracts, retinopathy, and macular edema). In pati...
Autores principales: | Martinez, Bridget, Peplow, Philip V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676865/ https://www.ncbi.nlm.nih.gov/pubmed/31290435 http://dx.doi.org/10.4103/1673-5374.259602 |
Ejemplares similares
-
MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progression
por: Martinez, Bridget, et al.
Publicado: (2019) -
MicroRNAs as disease progression biomarkers and therapeutic targets in experimental autoimmune encephalomyelitis model of multiple sclerosis
por: Martinez, Bridget, et al.
Publicado: (2020) -
MicroRNAs as biomarkers in glaucoma and potential therapeutic targets
por: Martinez, Bridget, et al.
Publicado: (2022) -
MicroRNAs as potential biomarkers for diagnosis of attention deficit hyperactivity disorder
por: Martinez, Bridget, et al.
Publicado: (2023) -
MicroRNAs as diagnostic and prognostic biomarkers of age-related macular degeneration: advances and limitations
por: Martinez, Bridget, et al.
Publicado: (2020)